Spinnaker Trust Gilead Sciences, Inc. Transaction History

Spinnaker Trust

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 21, 2020	SELL	$72.34 - $84.0 $201,394 - $233,856	-2,784 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $174,361 - $223,332	2,784 New	2,784 $208,000
Q2 2018 Aug 02, 2018	SELL	$64.88 - $75.68 $183,675 - $214,250	-2,831 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$72.84 - $88.8 $206,210 - $251,392	2,831 New	2,831 $213,000

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Spinnaker Trust, based on Form 13F filings with the SEC.

Stay updated on Spinnaker Trust with notifications on news.